Aspartic Acid - Analogs & derivatives
Research News and Information

Saturday, November 21, 2009

Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord.

29 Sep 2009 Measuring in vivo spinal cord injury and repair remains elusive. Using magnetic resonance spectroscopy (MRS) we examined brainstem N-acetyl-aspartate (NAA) as a surrogate for spinal cord injury in two mouse strains with different reparative ... Read more...

Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport.

4 Sep 2009 Astrocytes are critical participants in synapse development and function, but their role in synaptic plasticity is unclear. Eph receptors and their ephrin ligands have been suggested to regulate neuron-glia interactions, and EphA4-mediated ephrin ... Read more...

[Long term clinical course of Canavan disease--a rare Japanese case]

30 Aug 2009 Canavan disease (CD), which is a rare disease in Japan, is an autosomal-recessive neurodegenerative disorder caused by mutations in aspartoacylase, an enzyme that deacetylates N-acetylaspartate to generate free acetate in the brain. CD affected ... Read more...

Latest indexed articles for 'Aspartic Acid - Analogs & derivatives'

These are the very latest articles for this heading:

• Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord. 29 Sep 2009
• Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. 4 Sep 2009
• [Long term clinical course of Canavan disease--a rare Japanese case] 30 Aug 2009
• Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls. 30 Aug 2009
• Prolonged neurologic course of familial hemophagocytic lymphohistiocytosis. 30 Aug 2009
• (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques. 30 Aug 2009
• Molecular neurodevelopment: an in vivo 31P-1H MRSI study. 11 Aug 2009
• Effect of chorioamnionitis on brain development and injury in premature newborns. 30 Jul 2009
• Measurement of glutathione in normal volunteers and stroke patients at 3T using J-difference spectroscopy with minimized subtraction errors. 30 Jul 2009
• pH-dependent self-assembling behavior of imidazole-containing polyaspartamide derivatives. 30 Jul 2009
• MRI- and MRS-derived hippocampal correlates of quantitative locomotor function in older adults. 21 Jul 2009
• Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart. 13 Jul 2009
• Use of short echo time two-dimensional 1H-magnetic resonance spectroscopy in temporal lobe epilepsy with negative magnetic resonance imaging findings. 29 Jun 2009
• Diabetic striatal disease: clinical presentation, neuroimaging, and pathology. 29 Jun 2009
• Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias. 29 Jun 2009
• MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia. 28 Jun 2009
• In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. 20 Jun 2009
• Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder. 13 Jun 2009
• How the MccB bacterial ancestor of ubiquitin E1 initiates biosynthesis of the microcin C7 antibiotic. 2 Jun 2009
• Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression. 30 May 2009

See a longer list of these articles.

Technical information about 'Aspartic Acid'

Definition: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.

Chemical name: L-Aspartic Acid

Registry Number: 56-84-8

Descriptor UI: D001224

Alternative terms: Aspartic Acid; L-Aspartic Acid; L Aspartic Acid; Monosodium Aspartate; Aspartate, Monosodium; Aspartic Acid, Monosodium Salt; (+-)-Aspartic Acid; (R,S)-Aspartic Acid; Ammonium Aspartate; Aspartate, Ammonium; Aspartic Acid, Ammonium Salt; Aspartate; L-Aspartate; L Aspartate; Aspartic Acid, Hydrobromide; Hydrobromide Aspartic Acid; Aspartic Acid, Hydrochloride; Hydrochloride Aspartic Acid; Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate; Aspartate Magnesium Hydrochloride; Hydrochloride, Aspartate Magnesium; Aspartic Acid, Magnesium-Potassium (2:1:2) Salt; Calcium Aspartate; Aspartate, Calcium; Aspartic Acid, Calcium Salt; Dipotassium Aspartate; Aspartate, Dipotassium; Aspartic Acid, Dipotassium Salt; Disodium Aspartate; Aspartate, Disodium; Aspartic Acid, Disodium Salt; Magnesiocard; Magnesium Aspartate; Aspartate, Magnesium; Aspartic Acid, Magnesium (2:1) Salt; Mg-5-Longoral; Mg 5 Longoral; Mg5Longoral; Monopotassium Aspartate; Aspartate, Monopotassium; Aspartic Acid, Monopotassium Salt; Potassium Aspartate; Aspartate, Potassium; Aspartic Acid, Potassium Salt; Sodium Aspartate; Aspartate, Sodium; Aspartic Acid, Sodium Salt;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D12.125.067.500; D12.125.119.170; D12.125.427.040;

Online Note: use ASPARTIC ACID (NM) to search ISOASPARTIC ACID 1990-92

History Note: 93; ISOASPARTIC ACID was (NM) 1990-92

Technical Notes: D-ASPARTIC ACID is also available